After the successful introduction of highly active antiretroviral agents the survival of patients infected with the human immunodeficiency virus (HIV) in developed countries has increased substantially. This has allowed the surfacing of several chronic diseases among which cardiovascular disease (CVD) is prominent. The pathogenesis of CVD in HIV is complex and involves a combination of traditional and HIV related factors. An accurate assessment of risk of CVD in these patients is still elusive and as a consequence the most appropriate preventive and therapeutic interventions remain controversial.

Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? / Shahbaz, Shima; Manicardi, Marcella; Guaraldi, Giovanni; Raggi, Paolo. - In: WORLD JOURNAL OF CARDIOLOGY. - ISSN 1949-8462. - STAMPA. - 7:10(2015), pp. 633-644.

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Powered by IRIS-about IRIS-Utilizzo dei cookie

 Copyright © 2020